1. Adiponectin-mediated promotion of CD44 suppresses diabetic vascular inflammatory effects
- Author
-
Duan, Yanru, Zhang, Shihan, Xing, Yuanyuan, Wu, Ye, Zhao, Wen, Xie, Pinxue, Zhang, Huina, Gao, Xinxiao, Qin, Yanwen, Wang, Yajing, Ma, Xinliang, Du, Yunhui, and Liu, Huirong
- Subjects
Multidisciplinary ,Article - Abstract
While adiponectin (APN) was known to significantly abolish the diabetic endothelial inflammatory response, the specific mechanisms have yet to be elucidated. Aortic vascular tissues from mice fed normal and high-fat diets (HFD) were analyzed by transcriptome analysis. GO functional annotation showed that APN inhibited vascular endothelial inflammation in an APPL1-dependent manner. We confirmed that activation of the Wnt/β-catenin signaling plays a key role in APN-mediated anti-inflammation. Mechanistically, APN promoted APPL1/reptin complex formation and β-catenin nuclear translocation. Simultaneously, we identified APN promoted the expression of CD44 by activating TCF/LEF in an APPL1-mediated manner. Clinically, the serum levels of APN and CD44 were decreased in diabetes; the levels of these two proteins were positively correlated. Functionally, treatment with CD44 C-terminal polypeptides protected diabetes-induced vascular endothelial inflammation in vivo. Collectively, we provided a roadmap for APN-inhibited vascular inflammatory effects and CD44 might represent potential targets against the diabetic endothelial inflammatory effect.
- Published
- 2023